Professor Daniel Hermens is a cognitive psychophysiologist who studies brain development, as well as psychiatric and substance use disorders in young people. He leads the Youth Mental Health & Neurobiology program and is the Deputy Director at the Sunshine Coast Mind and Neuroscience Thompson Institute. Daniel has training and expertise in youth mental health, cognitive psychophysiology, neuropsychology, neuroimaging, substance misuse and clinical trials. He has extensive expertise in conducting large neurobiologically informed longitudinal cohort studies, with multimodal (neuropsychological, neuroimaging) datasets of various patient groups, such as depression, psychosis, bipolar disorder and substance misuse.
He was the first to describe sex-based differences in patterns of nervous system activity in ADHD, and consequently, helped to predict which patients would respond best to stimulant vs non-stimulant medication. The resultant two publications were each in the ‘Top 25 Hottest Articles’ list in the respective journals. His other major contribution to neurobiology includes re-conceptualisation of the role of a biomarker for schizophrenia. Daniel’s more recent work has been to examine the neurobiological underpinning of alcohol-induced impairments in young people. His current research includes a prospective cohort study of early adolescents from the Sunshine Coast region. With a focus on neuroimaging and cognitive assessment, this study will examine the factors associated with mental health and wellbeing in the adolescent period. His research program also includes novel imaging studies examining the time-course of neurotransmitters and the brain effects of glutamatergic agents (e.g. ketamine, alcohol).